Tirzepatide API (Dual GLP-1/GIP Agonist) – ≥99% Purity for Metabolic Research

Short Description:

Tirzepatide (Dual GLP-1/GIP Receptor Agonist)Product Name: Tirzepatide APICAS No.: 2023788-19-2Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈Molecular Weight: 4813.45 g/molPurity: 99% (HPLC) —...


Product Detail

Product Tags

Tirzepatide (Dual GLP-1/GIP Receptor Agonist)

Product Name: Tirzepatide API

CAS No.: 2023788-19-2

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight: 4813.45 g/mol

Purity: ≥99% (HPLC) — third-party verified

Appearance: White to off-white lyophilized powder

Solubility: Soluble in water and dilute buffers

Form: Sterile lyophilized powder in vacuum-sealed vials

Storage: -20°C, protected from light and moisture

Shelf Life: 24 months under recommended storage conditions

Packaging Options: 10mg, 50mg, 100mg, 1g, 5g (bulk quantities available for qualified pharmaceutical manufacturers)

Trizepatide.jpg

Product Description

Tirzepatide is a first-in-class dual receptor agonist that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It represents a significant advancement in peptide therapeutics for metabolic disorders.

Mechanism of Action:

  • Activates GLP-1 receptors to enhance insulin secretion and suppress appetite

  • Stimulates GIP receptors to improve metabolic response and energy utilization

  • Dual activation produces synergistic effects on glycemic control and weight reduction

  • Once-weekly dosing profile suitable for chronic administration

Clinical Research Profile:
In published clinical trials, Tirzepatide has demonstrated:

  • Approximately 20% mean body weight reduction over 72 weeks at higher doses

  • Superior HbA1c reduction compared to selective GLP-1 agonists

  • Favorable gastrointestinal tolerability profile

  • Improvements in cardiovascular risk markers

Research Applications:

  • Type 2 diabetes and obesity research

  • Dual receptor agonist mechanism studies

  • Metabolic syndrome investigations

  • Cardiovascular outcomes research

  • Reference standard for analytical method development

Quality Assurance

  • Manufactured in alignment with GMP guidelines

  • Purity verified by HPLC (≥99%)

  • Mass spectrometry confirmation for molecular identity

  • Certificate of Analysis (CoA) provided with each shipment

  • Residual solvent analysis available upon request

  • Stability data available for qualified research institutions

Important Notice

All peptide products supplied by Jintai Sheng are intended for verified pharmaceutical manufacturers and research institutions only. We do not sell to individual consumers. This product is for research and manufacturing use only—not for human or veterinary use.

Need complete technical specifications? For detailed information including residual solvent analysis, mass spectrometry data, and stability studies, please contact our commercial representatives. We typically respond within 24 hours on business days.


Leave Your Message


Write your message here and send it to us
 Jintai Sheng BioTech - Footer

Leave Your Message